FDA Turns Down Testosterone Pellet Petition

The FDA denied a petition from several pharmaceutical and outsourcing facilities urging the agency to keep implantable testosterone pellets off its Difficult to Compound list — but noted that so far it hasn’t made any moves to include it.
Source: Drug GMP Report